Henry Schein, Inc.
HSIC
Positions held
Your positionsHSIC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Henry Schein operates in a stable healthcare sector with consistent demand for medical distribution services.
- In Q2 2026, revenue increased by 3% compared to the previous quarter, reaching $3.5 billion.
- The company reported a gross margin of 31.8%, maintaining stability from the prior quarter.
- The company's current score indicates a 'Strong Sell' signal, reflecting negative market sentiment.
- Henry Schein's trailing P/E ratio is 24.73, suggesting it may be overvalued compared to industry averages.
- The debt-to-equity ratio stands at 80.73, indicating a high level of leverage that could pose risks.
Fundamentals
| Market cap | $9.43B | Enterprise value | $14.65B | Trailing P/E | 24.67 | Forward P/E | 14.14 |
| PEG | 1.67 | Price / book | 3.00 | Beta | 0.84 | Dividend yield | 0.00% |
| Revenue growth | 6.7% | Earnings growth | 17.1% | Gross margin | 31.3% | Operating margin | 5.8% |
| Profit margin | 3.0% | ROE | 8.9% | ROA | 4.4% | Debt / equity | 0.81 |
| Current ratio | 1.32 | Free cash flow | $446.00M | Analyst recommendation | buy | Mean target | $97.27 |
| 52w high | $92.18 | 52w low | $61.95 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.4B | $3.4B | $3.3B | $3.2B | — |
| Op margin | 5.8% | 5.8% | 5.4% | 5.9% | 5.4% | — |
| Net income | $94.0M | $107M | $101M | $101M | $86.0M | — |
| Gross margin | 31.8% | 31.8% | 30.9% | 30.7% | 31.4% | — |
| Gross profit | $1.1B | $1.1B | $1.1B | $1.0B | $1.0B | — |
| Operating income | $200M | $194M | $186M | $198M | $174M | — |
- Revenue +3% vs prior quarter ($3.5B vs $3.4B).
- Gross margin 31.8% (was 31.8% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $13.2B | $12.7B | $12.3B | $12.6B | — |
| Op margin | 5.7% | 5.8% | 5.6% | 6.9% | — |
| Net income | $398M | $390M | $416M | $538M | — |
| Gross margin | 31.1% | 31.7% | 31.3% | 30.3% | — |
| Gross profit | $4.1B | $4.0B | $3.9B | $3.8B | — |
| Operating income | $758M | $731M | $695M | $878M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Henry Schein Names Emmanuel Caprais CFO
2026-10-08 · Henry Schein Announces Chief Financial Officer Leadership Transition
2026-10-08 · 3 Low-Volatility Stocks with Open Questions
2026-10-06 · HSIC or MMSI: Which Is the Better Value Stock Right Now?
2026-10-06 · Should Value Investors Buy Henry Schein (HSIC) Stock?
2026-09-30 · Henry Schein Cares Marks 25 Years of Helping Health Happen®
2026-09-28 · Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings?
2026-09-27 · Henry Schein (HSIC) Extends Credit Facility, Is The Stock Still Undervalued?
2026-09-26 · Henry Schein (HSIC) Stock Looks Below Fair Value Even After A 31% Gain
2026-09-25 · 3 Cash-Producing Stocks That Concern Us
2026-09-25 · Is Henry Schein Stock Outperforming the Dow?
Price (daily)
Full chart · RSI · MACD · patterns